Table 1.
Characteristics of invasive beta-haemolytic streptococci (BHS) and group A, B, C and G streptococci (GAS, GBS, GCS and GGS, respectively) in Denmark from 2005 to 2011
GAS (n = 994) | GBS (n = 767) | GCS (n = 233) | GGS (n = 984) | All BHS (n = 2978) | |
---|---|---|---|---|---|
Isolates from clinical material (%) | |||||
Blood | 93.1 | 93.2 | 97.4 | 96.9 | 94.7 |
Cerebrospinal fluid | 1.4 | 4.0 | 0.4 | 0.3 | 1.6 |
Other sterile material | 5.5 | 2.7 | 2.2 | 2.9 | 3.7 |
Patient information, age (years) | |||||
Median age | 63.2 | 62.2 | 68.7 | 71.2 | 66.2 |
Age interquartile rangea | 42.3–75.2 | 35.1–75.9 | 58.0–79.0 | 60.5–81.7 | 50.3–78.6 |
Age range | 0–99 | 0–98 | 0–100 | 0–100 | 0–100 |
Age group (years) related incidence | |||||
0–4 | 2.54 | 6.31 | 0.09 | 0.35 | 9.29 |
5–19 | 0.45 | 0.08 | 0.06 | 0.06 | 0.65 |
20–64 | 1.95 | 1.18 | 0.38 | 1.51 | 5.02 |
≥65 | 7.56 | 5.75 | 2.32 | 10.36 | 25.98 |
All ages | 2.59 | 2.00 | 0.61 | 2.56 | 7.76 |
Sex and age group (years) related incidence | |||||
Incidence in men | |||||
0–4 | 2.31 | 6.33 | 0.09 | 0.43 | 9.15 |
5–19 | 0.49 | 0.05 | 0.03 | 0.05 | 0.63 |
20–64 | 1.90 | 1.23 | 0.48 | 1.75 | 5.36 |
≥65 | 8.23 | 7.36 | 2.85 | 14.34 | 32.78 |
All ages | 2.54 | 2.17 | 0.69 | 3.09 | 8.49 |
Incidence in women | |||||
0–4 | 2.78 | 6.29 | 0.09 | 0.27 | 9.43 |
5–19 | 0.40 | 0.12 | 0.09 | 0.06 | 0.66 |
20–64 | 2.00 | 1.12 | 0.28 | 1.27 | 4.68 |
≥65 | 7.03 | 4.50 | 1.91 | 7.27 | 20.71 |
All ages | 2.64 | 1.83 | 0.52 | 2.05 | 7.05 |
Sex incidence ratio (M:F) | 0.96 | 1.19 | 1.33 | 1.51 | 1.20 |
Antibiotic resistant (%) | |||||
Penicillin | 0 | 0 | 0.9b | 0 | |
Erythromycin | 1.9 | 9.2 | 1.1 | 7.7 | |
Clindamycin | 0.5 | 5.4 | 0.3 | 1.1 | |
Tetracycline | 4.3 | 48.1 | 0.3 | 22.9 |
Kruskal–Wallis equality-of-populations range test, χ2 = 165.011 with 3 d.f., p 0.0001.
MIC values of two isolates were 0.5 and 1 mg/L and above the breakpoint of 0.25 mg/L; the MIC determinations were confirmed by a different laboratory.